G Medical Innovations Holdings Ltd (GMVDF) Stock
G Medical Innovations Holdings Ltd operates as an emerging healthcare enterprise, focused on pioneering advanced mobile health and remote medical solutions across the United States, China, and Israel. Its product line includes Prizma, an intuitive medical device for measuring vital signs, which also incorporates electronic medical record functionality and adheres to clinical-grade reporting standards.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd operates as an emerging healthcare enterprise, focused on pioneering advanced mobile health and remote medical solutions across the United States, China, and Israel. Its product line includes Prizma, an intuitive medical device for measuring vital signs, which also incorporates electronic medical record functionality and adheres to clinical-grade reporting standards. Another offering is the Extended Holter Patch System, a multi-channel biosensor worn by patients that continuously records ECG data for up to two weeks. The company is also in the process of developing a Wireless Vital Signs Monitoring System, aiming to provide uninterrupted, real-time tracking of physiological parameters and biometrics. Furthermore, G Medical Innovations offers comprehensive monitoring services, encompassing both support for independent diagnostic testing facilities and personalized private monitoring solutions. Established in 2014, the company's corporate headquarters are located in Rehovot, Israel.
G Medical Innovations Holdings Ltd (GMVDF) stock trades at $0.00 with a market capitalization of $25992. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.03, and currently trades 100.0% below its 52-week high.
On profitability, G Medical Innovations Holdings Ltd generates a return on equity (ROE) of 357.14% — well above the market average, a sign of a high-quality business, return on capital employed of 515.69%, an operating margin of -301.50%, a net profit margin of -625.00%.
Official website: gmedinnovations.com